VentriPoint Diagnostics: Pioneering 3‑D Heart Disease Imaging for Better Outcomes
VentriPoint Diagnostics turns 2‑D images into 3‑D heart models, boosting heart disease diagnosis for cardiologists.
2 minutes to read
VentriPoint Diagnostics Ltd
VentriPoint Diagnostics Faces Financial Struggles Amid Innovative Heart‑Disease Tech
VentriPoint Diagnostics Ltd.
2 minutes to read
VentriPoint Diagnostics: Pioneering 3‑D Heart Imaging to Drive Growth on TSX Venture
VentriPoint Diagnostics transforms 2‑D imaging into 3‑D heart models, boosting early heart‑disease detection. Learn how their tech and growth strategy shape the future of cardiac care.
2 minutes to read
VentriPoint Diagnostics Faces Sharp Decline: Investor Confidence in Jeopardy Amidst 3D Heart Imaging Innovation
VentriPoint Diagnostics Ltd.
3 minutes to read
VentriPoint Diagnostics Advances Heart Disease Diagnostics with Innovative 3D Modeling Technology
VentriPoint Diagnostics Ltd., a Canadian company, is making strides in heart disease diagnostics with its innovative technology that creates 3D models from existing device images, positioning it for potential future growth and profitability.
2 minutes to read
VentriPoint Diagnostics Announces Sales Growth Strategy with VMS+ and Strategic Partnerships
VentriPoint Diagnostics Ltd. has issued a corporate update highlighting its focus on expanding sales through its VMS+ platform and strategic partnerships, positioning the company for growth in the cardiovascular diagnostics market.
3 minutes to read
VentriPoint Diagnostics Leads Innovation in Heart Disease Diagnostics with 3D Imaging Technology
VentriPoint Diagnostics Ltd. is a Canadian company pioneering innovative heart disease diagnostics with cutting-edge technology that transforms images into 3D models, offering a promising opportunity for investors and a potential game-changer in car…
3 minutes to read